| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/03/2013 | US8598233 Method for administering an NMDA receptor antagonist to a subject |
| 12/03/2013 | US8598218 Liquid pharmaceutical formulations of palonosetron |
| 12/03/2013 | US8598203 Treatment of Crohn's disease with laquinimod |
| 12/03/2013 | US8598191 Controlled release compositions of gamma-hydroxybutyrate |
| 12/03/2013 | US8598129 Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
| 12/03/2013 | US8598124 Peptides derived from HMG-CoA reductase and cosmetic and/or pharmaceutical composition containing same |
| 12/03/2013 | US8597932 Cell culture of micorrhizal fungus and arthrobacter histidinolovorans |
| 12/03/2013 | US8597716 Methods to increase fracture resistance of a drug-eluting medical device |
| 12/03/2013 | US8597686 Porous cellulose aggregate and formed product composition comprising the same |
| 12/03/2013 | US8597685 Method for production of particles of pharmaceutical substances particles of pharmaceutical substances and the use thereof |
| 12/03/2013 | US8597684 Modified release formulations containing drug-ion exchange resin complexes |
| 12/03/2013 | US8597683 Modified release tranexamic acid formulation |
| 12/03/2013 | US8597681 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
| 12/03/2013 | US8597680 Microtablets for drug delivery |
| 12/03/2013 | US8597679 Fine-particle crosslinked polyvinylpyrrolidone as tablet disintegrant |
| 12/03/2013 | US8597678 Nanolipidic particles |
| 12/03/2013 | US8597674 In situ blood vessel and aneurysm treatment |
| 12/03/2013 | US8597666 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
| 12/03/2013 | US8597664 Endogenous adjuvant molecules and uses thereof |
| 12/03/2013 | US8597654 Adjuvant therapy with an anti-ERBB2 antibody conjugated to a maytansiniod |
| 12/03/2013 | US8597629 Artificial tear compositions comprising a combination of nonionic surfactants |
| 12/03/2013 | US8597616 Dry powder drug delivery formulations, methods of use, and devices therefore |
| 12/03/2013 | US8597279 Swallowable multi-nozzle dosing device for releasing medicines in the gastrointestinal tract |
| 12/03/2013 | US8597278 Medicament delivery system and process |
| 12/03/2013 | US8597244 Infusion pump system, an infusion pump unit and an infusion pump |
| 12/03/2013 | CA2768458C Subcutaneous anti-her2 antibody formulation |
| 12/03/2013 | CA2723470C Nasal administration of benzodiazepines |
| 12/03/2013 | CA2702604C Transdermal drug delivery using an osmolyte and vasoactive agent |
| 12/03/2013 | CA2694235C Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
| 12/03/2013 | CA2677185C Method for preparing particles comprising metal oxide coating and particles with metal oxide coating |
| 12/03/2013 | CA2637408C Foam-forming composition |
| 12/03/2013 | CA2606073C Ophthalmic devices for sustained delivery of active compounds |
| 12/03/2013 | CA2601800C Oral drug delivery system |
| 12/03/2013 | CA2574614C Sterile freezing, drying, storing, assaying and filling process (sfd-saf process) (pellet freeze-drying process for parenteral biopharmaceuticals) |
| 12/03/2013 | CA2565382C Use of a viscoelastic composition for treating increased intraocular pressure |
| 12/03/2013 | CA2527417C Ophthalmic compositions containing a synergistic combination of three polymers |
| 11/30/2013 | CA2817260A1 Microspheres including oxidized cellulose |
| 11/30/2013 | CA2817259A1 Microspheres including oxidized cellulose |
| 11/30/2013 | CA2790763A1 Aptamer bioconjugate drug delivery device |
| 11/30/2013 | CA2779052A1 Pharmaceutical composition of entecavir and process of manufacturing |
| 11/30/2013 | CA2778679A1 Use of stabilized granules containing glyceryl trinitrate for arteriogenesis |
| 11/28/2013 | WO2013177594A2 Xylitol-based anti-mucosal compositions and related methods and compositions |
| 11/28/2013 | WO2013177565A1 Insulin-pramlintide compositions and methods for making and using them |
| 11/28/2013 | WO2013177421A2 Lipid-coated albumin nanoparticle compositions and methods of making and method of using the same |
| 11/28/2013 | WO2013177419A2 Lipid nanoparticle compositions and methods of making and methods of using the same |
| 11/28/2013 | WO2013177364A1 Biomaterials suitable for use as drug eluting, magnetic resonance imaging detectable implants for vascular occlusion |
| 11/28/2013 | WO2013177226A1 Systems for treating pulmonary infections |
| 11/28/2013 | WO2013177194A1 Compositions and methods for decreasing leukocyte extravasation and vessel fluid leakage |
| 11/28/2013 | WO2013177176A1 Compositions and methods for inducing myoblast differentiation and myotube formation |
| 11/28/2013 | WO2013177147A2 Copolymer-xerogel nanocomposites useful for drug delivery |
| 11/28/2013 | WO2013177068A1 Implantable urological device with improved retrieval feature |
| 11/28/2013 | WO2013176702A1 Compositions and methods for antimicrobial metal nanoparticles |
| 11/28/2013 | WO2013176567A1 Pharmaceutical composition for the prophylaxis and treatment of psychological, behavioral and cognitive disorders |
| 11/28/2013 | WO2013176468A1 Liver targeted drug delivery systems using metal nanoparticles and preparing method thereof |
| 11/28/2013 | WO2013176455A1 Multilayer coating form of orally administered pharmaceutical composition containing omega-3 fatty acid or alkyl ester thereof and statin based drug |
| 11/28/2013 | WO2013176375A1 Temperature-sensitive anti-adhesive material |
| 11/28/2013 | WO2013176223A1 Pharmaceutical composition for treating inflammatory disease |
| 11/28/2013 | WO2013176220A1 Regulation of circadian rhythm |
| 11/28/2013 | WO2013175781A1 Pharmaceutical composition for inhalation |
| 11/28/2013 | WO2013175511A1 Taste masked pharmaceutical compositions |
| 11/28/2013 | WO2013175507A1 Novel highly bioavailable, water soluble and sustained release nanoformulations of hydrophobic plant derived compounds and extracts |
| 11/28/2013 | WO2013175500A1 Delazed release pharmaceutical compositions of salsalate |
| 11/28/2013 | WO2013175493A1 Stable oral pharmaceutical compositions |
| 11/28/2013 | WO2013175405A1 Co—processed excipient, obtained by spray—drying, usable as a pharmaceutical excipient or food additive |
| 11/28/2013 | WO2013175385A1 Bisphosphonates vinylic monomers and polymers and uses thereof |
| 11/28/2013 | WO2013175303A1 Acid resistant banding solution for two piece hard capsules |
| 11/28/2013 | WO2013175285A1 Process for preparing ophthalmic suspension of brinzolamde |
| 11/28/2013 | WO2013175088A1 No/nitrogen gaseous mixture with a high no content for the treatment of severe hypoxemic respiratory failure |
| 11/28/2013 | WO2013175011A1 Treatment of preadolescent moderate acne vulgaris |
| 11/28/2013 | WO2013174978A1 Somatostatin receptor agonist formulations |
| 11/28/2013 | WO2013174936A1 Aqueous pharmaceutical composition containing a biologic therapeutic agent and guanidine or a guanidine derivative and an injection including the composition |
| 11/28/2013 | WO2013174884A1 Capsules having an incorporated taste modifying component |
| 11/28/2013 | WO2013174883A1 Compositions comprising short-acting benzodiazepines |
| 11/28/2013 | WO2013174774A2 Cosmetic compositions comprising magnetosomes and uses thereof |
| 11/28/2013 | WO2013174753A1 Hybrid organic-inorganic nano-particles |
| 11/28/2013 | WO2013174752A2 System composed of inhaler and capsule |
| 11/28/2013 | WO2013174498A1 Dosage forms comprising apixaban and matrix former |
| 11/28/2013 | WO2013174409A1 Reversible immobilization and/or controlled release of nucleic acid containing nanoparticles by (biodegradable) polymer coatings |
| 11/28/2013 | WO2013174298A1 Method for selectively preparing mono-, and diester of erythritol and fatty acid |
| 11/28/2013 | WO2013174015A1 Cefixime granule and preparation method thereof |
| 11/28/2013 | WO2013173960A1 Traditional chinese medicine composition for treating lower respiratory tract viral infectious diseases and preparation method therefor |
| 11/28/2013 | WO2013173874A2 Composition and method for management of diabetes or pre-diabetes |
| 11/28/2013 | WO2013155493A9 Methods of treating inflammatory and autoimmune diseases and disorders |
| 11/28/2013 | WO2013128201A3 Structured silicon particles |
| 11/28/2013 | WO2013124700A3 Composition based on silybum marianum seed oil and process for the preparation of the seed oil |
| 11/28/2013 | US20130317624 Placental tissue grafts and improved methods of preparing and using the same |
| 11/28/2013 | US20130317462 Transdermal delivery system for hormones and steroids |
| 11/28/2013 | US20130317461 Compositions and methods for delivering estradiol in transdermal drug delivery systems |
| 11/28/2013 | US20130317122 Transdermal delivery system |
| 11/28/2013 | US20130317112 Storage-stable formulation of paracetamol in aqueous solution |
| 11/28/2013 | US20130317108 Dermatological foams obtained from a gel or suspension containing a combination of adapalene and benzoyl peroxide |
| 11/28/2013 | US20130317063 Oral controlled release pharmaceutical compositions of bepotastine |
| 11/28/2013 | US20130317053 Externally-used drug for treating skin disorder and method for producing same |
| 11/28/2013 | US20130317051 Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent |
| 11/28/2013 | US20130317008 Use of a Specific Cyclic Amine Derivative or the Pharmaceutically Acceptable Salts Thereof for the Treatment or Prevention of Heart Failure |
| 11/28/2013 | US20130316996 Transdermal delivery rate control using amorphous pharmaceutical compositions |
| 11/28/2013 | US20130316976 Pharmaceutical preparation |
| 11/28/2013 | US20130316026 Xylitol-based anti-mucosal compositions and related methods and compositions |
| 11/28/2013 | US20130316021 Treatment of respiratory diseases |
| 11/28/2013 | US20130316010 Polymeric microparticles |